The median pain score before using the Lidocaine Patch was 8, indicating significant pain levels. After one month of treatment, the overall median pain score decreased to 6, while current users reported an even lower median score of 5. This suggests that the lidocaine plaster is effective in reducing pain, with continued use potentially offering greater relief. Additionally, satisfaction scores were higher among current users (7) compared to all patients (5), highlighting better outcomes for those who maintained treatment.
Key Points Explained:
-
Baseline Pain Level:
- The median pain score before treatment was 8, reflecting a high level of discomfort. This establishes a clear starting point for evaluating the plaster's efficacy.
-
Post-Treatment Pain Reduction:
- After one month, the overall median pain score dropped to 6, demonstrating a measurable improvement.
- Current users (those still applying the plaster) reported a further reduction to 5, suggesting sustained or enhanced benefits with ongoing use.
-
Satisfaction Scores:
- The median satisfaction score for all patients was 5, while current users reported 7. This disparity implies that adherence to treatment correlates with higher patient satisfaction.
-
Clinical Implications:
- The data supports the Lidocaine Patch as a viable option for pain management, particularly for patients committed to long-term use.
- The difference between overall and current-user scores underscores the importance of patient compliance in achieving optimal results.
-
Practical Considerations for Purchasers:
- Efficacy and patient satisfaction metrics can guide procurement decisions, especially for facilities prioritizing non-opioid pain relief.
- The plaster’s progressive benefits (e.g., lower scores for current users) may justify bulk purchasing or extended prescription plans.
By linking pain reduction to satisfaction, this analysis offers actionable insights for healthcare providers and purchasers alike. How might these findings influence your facility's approach to pain management protocols?
Summary Table:
| Metric | Before Treatment | After 1 Month (All Patients) | Current Users |
|---|---|---|---|
| Median Pain Score | 8 | 6 | 5 |
| Median Satisfaction Score | - | 5 | 7 |
Upgrade your pain management protocol with Enokon’s clinically effective lidocaine plasters.
As a bulk manufacturer of transdermal pain relief solutions, we equip healthcare distributors and brands with:
- Proven efficacy: Data shows sustained pain reduction (scores drop to 5 with continued use).
- Higher patient satisfaction: Adherent users report 40% better satisfaction (score 7 vs. 5).
- Custom R&D support: Tailor formulations or dosing protocols for your patient demographics.
Contact us today to discuss bulk orders or OEM partnerships. Let’s optimize your pain relief offerings together.
